| Literature DB >> 29429156 |
Seri Hong1, Mina Suh1, Kui Son Choi1,2, Boyoung Park1,2, Jae Myung Cha3, Hyun-Soo Kim4, Jae Kwan Jun1,2, Dong Soo Han5.
Abstract
Background/Aims: People around the world are increasingly choosing to undergo colorectal cancer screening via colonoscopy. As a result, guideline adherence to postpolypectomy colonoscopy surveillance has drawn increasing attention. The present study was performed to assess recognition and adherence to guidelines among primary care physicians and gastroenterologists and to identify characteristics associated with compliance.Entities:
Keywords: Colonoscopy; Colorectal neoplasms; Early detection of cancer; Guideline adherence
Mesh:
Year: 2018 PMID: 29429156 PMCID: PMC6027840 DOI: 10.5009/gnl17403
Source DB: PubMed Journal: Gut Liver ISSN: 1976-2283 Impact factor: 4.519
Characteristics of Survey Respondents
| Characteristic | Primary physicians | Gastroenterologists | p-value |
|---|---|---|---|
| Overall response | 241 (63.6) | 138 (36.4) | |
| Sex | 0.106 | ||
| Male | 215 (88.6) | 105 (81.9) | |
| Female | 26 (11.4) | 33 (18.1) | |
| Age, yr | 0.013 | ||
| 30–39 | 34 (15.2) | 59 (24.6) | |
| 40–49 | 121 (49.3) | 61 (32.5) | |
| ≥50 | 86 (35.5) | 18 (42.8) | |
| Years in practice | 0.298 | ||
| <10 | 16 (6.1) | 29 (12.1) | |
| 10–19 | 93 (40.7) | 72 (34.6) | |
| 20–29 | 100 (40.6) | 33 (44.2) | |
| ≥30 | 30 (12.7) | 4 (9.0) | |
| Specialty | NA | ||
| Gastroenterology | 0 | 138 (100.0) | |
| General internal medicine | 195 (80.3) | 0 | |
| General surgery | 28 (11.6) | 0 | |
| Family medicine | 12 (5.5) | 0 | |
| Others | 6 (2.6) | 0 | |
| Type of medical facility | NA | ||
| Clinic | 240 (99.5) | 28 (24.7) | |
| Hospital | 1 (0.5) | 14 (8.6) | |
| General hospital | 0 | 30 (20.6) | |
| Tertiary hospital | 0 | 66 (46.1) | |
| No. of patients/day | <0.001 | ||
| <25 | 13 (5.9) | 25 (13.0) | |
| 25–49 | 50 (21.8) | 59 (37.1) | |
| 50–99 | 142 (58.3) | 50 (45.8) | |
| ≥100 | 36 (14.0) | 4 (4.2) |
Data are presented as unweighted numbers (weighted proportions).
NA, not available.
Rao-Scott modified chi-square test;
Missing: 2.
Responses from Korean Doctors on Postpolypectomy Follow-up Surveillance Recommendations in Comparison to Guideline Recommendations
| Clinical scenario | Recommendation in Korean guidelines, yr | Responses on follow-up surveillance intervals | |||||
|---|---|---|---|---|---|---|---|
|
| |||||||
| 6 mo | 1 yr | 3 yr | 5 yr | 10 yr | No repetition | ||
| 6-mm Hyperplastic polyp | 5 | 1 (0.2) | 33 (7.0) | 124 (28.9) | 210 (61.1) | 9 (2.7) | 1 (0.2) |
| 6-mm TA | 5 | 4 (0.7) | 117 (26.9) | 182 (48.6) | 71 (23.5) | 1 (0.3) | 0 |
| 12-mm TA with HGD | 3 | 163 (34.1) | 168 (49.4) | 44 (15.8) | 2 (0.7) | 0 | 0 |
| 12-mm TVA | 3 | 99 (20.2) | 191 (48.4) | 84 (30.3) | 3 (1.0) | 0 | 0 |
| Two 6-mm TAs | 5 | 13 (2.2) | 150 (31.8) | 157 (47.3) | 55 (18.3) | 1 (0.4) | 0 |
| No polyps in a patient with a 12-mm TA 3 yr earlier | 5 | 2 (0.4) | 18 (3.2) | 159 (41.4) | 196 (52.9) | 3 (2.1) | 0 |
Data are presented as unweighted numbers (weighted proportions). Non-respondents to each question were excluded.
TA, tubular adenoma; HGD, high-grade dysplasia; TVA, tubulovillous adenoma.
The U.S. Multi-Society Task Force recommends an interval of 10 years; the European panel (EPAGE II) recommends 5.5 years;
The U.S. Multi-Society Task Force recommends an interval of 5–10 years; the European panel (EPAGE II) recommends 5 years.
Fig. 1Distribution of postpolypectomy follow-up surveillance responses.
TA, tubular adenoma; TVA, tubulovillous adenoma; HGD, high-grade dysplasia. *Recommended intervals in Korean guidelines; †Recommended intervals in the U.S. Multi-Society Task Force guideline.
Odds Ratios for Recommending an Appropriate Follow-up Colonoscopic Surveillance Interval in Comparison to Current Guidelines*
| Characteristic | Crude OR | Adjusted OR | ||
|---|---|---|---|---|
|
|
| |||
| Estimates | (95% CI) | Estimates | (95% CI) | |
| Sex | ||||
| Male | 1.00 | Reference | 1.00 | Reference |
| Female | 0.63 | (0.48–0.84) | 0.97 | (0.69–1.38) |
| Age, yr | ||||
| 30–39 | 1.00 | Reference | 1.00 | Reference |
| 40–49 | 0.54 | (0.43–0.67) | 0.53 | (0.40–0.72) |
| ≥50 | 0.52 | (0.37–0.74) | 0.50 | (0.34–0.75) |
| Specialty | ||||
| Gastroenterology | 1.00 | Reference | 1.00 | Reference |
| General internal medicine | 0.33 | (0.26–0.41) | 1.57 | (0.92–2.70) |
| General surgery | 0.13 | (0.08–0.23) | 0.70 | (0.33–1.51) |
| Family medicine or others | 0.18 | (0.09–0.35) | 0.93 | (0.40–2.17) |
| Type of medical facility | ||||
| Clinic | 0.11 | (0.08–0.15) | 0.09 | (0.05–0.17) |
| Hospital | 0.22 | (0.13–0.39) | 0.18 | (0.11–0.31) |
| General hospital | 0.38 | (0.23–0.61) | 0.35 | (0.21–0.58) |
| Tertiary hospital | 1.00 | Reference | 1.00 | Reference |
| No. of patients/day | ||||
| <25 | 0.91 | (0.61–1.34) | 0.58 | (0.34–1.00) |
| 25–49 | 1.00 | Reference | 1.00 | Reference |
| 50–99 | 0.87 | (0.65–1.15) | 1.09 | (0.77–1.54) |
| ≥100 | 0.23 | (0.14–0.35) | 0.54 | (0.32–0.91) |
OR, odds ratio; CI, confidence interval.
Adequate intervals include recommendations of the Korean and other international (U.S. and Europe) guidelines;
Adjusted for sex, age, specialty, type of medical facility, and number of patients per day.